Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: MELANOMA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Nayane de et al. Evaluation of invasive potential inhibition in vemurafenib-resistant melanoma cell lines after DM-1 treatment. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 out. 2024. , 2015APA
Souza, N. de, Takashi, G., Flores, F. F., Pennacchi, P. C., Suárez, J. A. P. Q., & Maria-Engler, S. S. (2015). Evaluation of invasive potential inhibition in vemurafenib-resistant melanoma cell lines after DM-1 treatment. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Souza N de, Takashi G, Flores FF, Pennacchi PC, Suárez JAPQ, Maria-Engler SS. Evaluation of invasive potential inhibition in vemurafenib-resistant melanoma cell lines after DM-1 treatment. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 4 res. FCF004.[citado 2024 out. 14 ]Vancouver
Souza N de, Takashi G, Flores FF, Pennacchi PC, Suárez JAPQ, Maria-Engler SS. Evaluation of invasive potential inhibition in vemurafenib-resistant melanoma cell lines after DM-1 treatment. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 4 res. FCF004.[citado 2024 out. 14 ]